Evidence map›Paper›PMID 33951899›Full record

ReviewTurkish journal of ophthalmology2021

Congenital Cataract and Its Genetics: The Era of Next-Generation Sequencing

Hande Taylan Şekeroğlu, Gülen Eda Utine

Open access · diamondAbstract readReview
In one paragraph

Review in Turkish journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of theGenes · 2025
    Article
  8. Article
  9. NovelInternational journal of ophthalmology · 2024
    Article
  10. Characterization of NInternational journal of ophthalmology · 2024
    Article
  11. Article
  12. Mutations of CX46/CX50 and Cataract Development.Frontiers in molecular biosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hande Taylan ŞekeroğluHacettepe University Faculty of Medicine, Department of Ophthalmology, Ankara, TurkeyORCID 0000-0002-4783-522X
Gülen Eda UtineHacettepe University Faculty of Medicine, Department of Pediatrics, Department of Pediatric Genetics, Ankara, TurkeyORCID 0000-0001-6577-5542
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital cataract is a challenging ophthalmological disorder which can cause severe visual loss. It can be diagnosed at birth or during the first year of life. Early diagnosis and treatment are crucial for the visual prognosis. It can be associated with various ocular and systemic abnormalities. Determining whether congenital cataract is isolated or associated with other pathology is an indispensable step for the prediction of potential vision as well as early diagnosis and treatment of conditions that can cause morbidity or mortality. Many genes have been identified in the molecular etiology of congenital cataract. Most mutations have been reported in the crystallin genes. Determination of the genetic cause may not only enable individualized genetic counseling but also help to identify concomitant ocular and/or systemic disorders depending on the characteristics of the genetic test used. Recently, next-generation sequencing in particular has become an evolving technology for determining the molecular etiology of congenital cataract and furthering our knowledge of the disease.

Indexed as

MutationCataractCrystallinsGenetic TestingHigh-Throughput Nucleotide SequencingHumansPedigreeCrystallinscongenital cataractcrystallinGeneticslensnext-generation sequencing

Identifiers

PMID33951899
PMCPMC8109038
OpenAlexW3157100355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.